Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000065

CEO bought 4,000 shares at an average $0.23 ($934)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-11-20 Purchase : show line 1 in the form +2,500 $0.22 $550 6,165,876 D
2015-11-23 Purchase : show line 2 in the form +1,500 $0.26 $384 6,167,376 D
Open-market purchases · 4,000 sh · avg $0.23 · $934
Loading xslF345X03/primary_doc.xml…